SMA Patient Gives Advice About Clinical Trials

  Jim Willson, a patient with spinal muscular atrophy (SMA) who is currently in a clinical trial for risdiplam (Evrysdi), gives advice to physicians and patients thinking about being part of a clinical trial. SMA is a genetic disease that affects motor neurons in...

Treatment Options for Hodgkin’s Lymphoma

  John Kuruvilla, MD, from the Princess Margaret Cancer Centre provides an overview of treatment options for persons with Hodgkin’s lymphoma. Hodgkin’s lymphoma is a rare cancer that is usually treated initially with salvage therapy and autologous stem cell...

SMA Patient Discusses His Experience with Risdiplam

  Jim Willison, a patient with spinal muscular atrophy (SMA), discusses his experience being part of a clinical trial for risdiplam (Evrysdi). SMA is a genetic disease that affects motor neurons in the spinal cord and control of muscle movement. It is caused by a...